CHK2 Gene and Hereditary Breast Cancer
Author Information
Author(s): Allinen M, Huusko P, Mäntyniemi S, Launonen V, Winqvist R
Primary Institution: Department of Clinical Genetics, University of Oulu/Oulu University Hospital, Oulu, Finland
Hypothesis
Does the CHK2 gene contribute to hereditary breast cancer risk in Finnish families?
Conclusion
CHK2 mutations do not significantly contribute to hereditary breast cancer risk in the Finnish population.
Supporting Evidence
- Only one missense-type mutation was detected in the study.
- 21 families met the criteria for Li–Fraumeni-like syndrome.
- All families were negative for BRCA1, BRCA2, and TP53 mutations.
Takeaway
The study looked at families with hereditary breast cancer to see if a gene called CHK2 was causing the problem, but it turns out it probably isn't.
Methodology
Screened 79 Finnish hereditary breast cancer families for germline CHK2 alterations.
Limitations
Only one mutation was found, and the study was limited to the Finnish population.
Participant Demographics
Finnish hereditary breast cancer families.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website